P. Zeynalova

发表

The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations

A. Stroganova, M. Dolgushin, A. Krylov, 2020, Oncohematology.

Treatment of primary central nervous system lymphomas

V. Lunin, A. Fedenko, I. Cherkashina, 2021, Oncohematology.

Successful use of ultrasound elastography in the preliminary intermediate evaluation of therapeutic response in patients with Hodgkin’s lymphoma

T. Danzanova, E. V. Kovaleva, P. Zeynalova, 2019, Oncohematology.

The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies

V. Lunin, Y. Timofeev, P. Zeynalova, 2019, Oncohematology.

Work-up and management of a high-risk patient with primary central nervous system lymphoma

M. Dolgushin, P. Zeynalova, M. Akhmedov, 2016, Cancer biology & medicine.

Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma

G. Tumyan, P. Zeynalova, N. Avxentyev, 2020, Oncohematology.

The role of monoclonal antibodies in treatment of refractory multiple myeloma

A. Akhobekov, P. Zeynalova, N. Kupryshina, 2022, MD-Onco.

Effectiveness of D-Rd program in the first line therapy of a 75-year-old female patient with multiple myeloma with high-risk cytogenetics. Clinical observation

P. Zeynalova, N. Kupryshina, F. M. Abbasbeyli, 2022, MD-Onco.

Clinical observation of a 64-year-old female patient with plasma cell leukemia diagnosed during coronavirus infection COVID-19

V. E. Gruzdev, A. Akhobekov, P. Zeynalova, 2022, MD-Onco.

MALT lymphoma and erosive and ulcerative lesions of the stomach: modern diagnostic approaches and own clinical observation

V. Lozovaya, S. Vorobyov, I. Bakulin, 2019, Oncohematology.

Plasma cell tumors of the head and neck. Analysis of diagnostic difficulties based on literature and own data

A. Mudunov, L. Grivtsova, P. Zeynalova, 2021, Oncohematology.

BRAF-mutant melanoma of the skin during pregnancy with dichorionic diamniotic twins. Clinical case

E. Bogush, O. Sinitsyna, M. Chekalova, 2021, MD-Onco.

Primary cutaneous diffuse large B-cell lymphoma, leg type, in an 80-year-old female patient. Clinical case

P. Zeynalova, F. M. Abbasbeyli, Y. Ryabukhina, 2022, MD-Onco.

Flow cytometry in the diagnosis of plasma cell tumors and assessment of minimal residual disease

V. Lunin, L. Grivtsova, T. Mushkarina, 2021, Oncohematology.

Immunophenotypic study of bone marrow erythrokaryocyte differentiation in patients with diffuse large B-cell lymphoma

N. Tupitsyn, P. Zeynalova, Cheng Jiao, 2019, Russian Journal of Biotherapy.

Lymphoproliferative disorders affecting organs of the head and neck

A. Akhundov, I. Gelfand, A. Batsev, 2022, Head and Neck Tumors (HNT).

Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol)

G. A. Davydova, V. Vorobiev, V. Savchenko, 2018, Oncohematology.

Successful experience in the use of ultrasound elastography in the differentiating of lymphomatous and metastatic superficial lymphadenopathy

I. V. Kolyadina, T. Danzanova, E. V. Kovaleva, 2020, Oncohematology.

Evaluation of the possibilities of shear wave elastography for differentiation of lymphomatous and reactive changes of superficial lymph nodes

T. Danzanova, E. V. Kovaleva, P. Zeynalova, 2020, Oncohematology.

Prognostically significant bone marrow cellular content changes in diffuse large B-cell lymphoma

P. Zeynalova, Cheng Jiao, 2019, Russian Journal of Biotherapy.

Prevention of induced nausea and vomiting in patients with malignant blood disorders. Experience of using netupitant/palonosetron (Akynzeo)

P. Zeynalova, F. M. Abbasbeyli, Y. Ryabukhina, 2022, MD-Onco.

Vaccination against SARS-COV‑2 in oncology

A. Fedenko, P. Zeynalova, A. Polyakov, 2021 .

Expert Council Review “Multiple myeloma”

P. Zeynalova, M. I. Akhmedov, 2023, Oncohematology.

Cancer alertness as a basis for timely diagnosis and effectiveness of therapy: A review

S. Mikhaylova, P. Zeynalova, T. Belysheva, 2023, Pediatrics. Consilium Medicum.

Experience with the use of bendamustine (Rozustin®): safety and efficacy

T. Valiev, G. Tumyan, P. Zeynalova, 2020, Oncohematology.

Use of μ1-opioid receptor agonist tafalgin in integrative therapy of chronic pain syndrome in progressive multiple myeloma. Clinical observation

V. E. Gruzdev, T. Valiev, P. Zeynalova, 2023, MD-Onco.

Clinical case of a 44-year-old patient with newly diagnosed peripheral T-cell lymphoma unspecified (Lennert’s lymphoma) and Loeffler’s endocarditis

L. A. Shestakova, A. Akhobekov, P. Zeynalova, 2023, Oncohematology.

New drug formulations of colony-stimulating factors in oncohematology

T. Valiev, P. Zeynalova, R. R. Fatkhullin, 2023, Oncohematology.

Safe drug therapy in clinical practice: experience of using microinfusion single-use mechanical systems in treatment of patients with malignant diseases of hematopoietic tissue and solid tumors

V. E. Gruzdev, A. Fedenko, P. Zeynalova, 2022, MD-Onco.

Erdheim–Chester disease. Literature review and clinical case

T. Valiev, E. Sushentsov, A. Stroganova, 2020, Oncohematology.

CDK4/6 inhibitors in combination with hormone therapy in clinical practice. Clinical case

A. Fedenko, D. Chekini, A. Y. Kolesnik, 2022, MD-Onco.

Use of obinutuzumab in therapy of patients with newly diagnosed follicular lymphoma. Experience of the Oncohematology Division of the Clinical Hospital “Lapino”

T. Valiev, P. Zeynalova, G. Allakhverdieva, 2023, MD-Onco.

A case of combination treatment of femoral osteosarcoma

A. Fedenko, D. Chekini, P. Zeynalova, 2022, MD-Onco.